SCHEMBL19784575

SCHEMBL19784575

COC(=O)C(c1ccccc1)c1cccc(OS(=O)(=O)C(F)(F)F)c1

nearest known ligand 0.44

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 3/20 0.43
CXCR2 P25025 2/20 0.42
TDP1 Q9NUW8 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.40
PTGS1 P23219 2/20 0.40
PTGS2 P35354 1/20 0.40
MEN1 O00255 2/20 0.39
KLK7 P49862 3/20 0.39
MTNR1A P48039 1/20 0.39
MTNR1B P49286 1/20 0.39
CXCR1 P25024 1/20 0.39
TACR1 P25103 1/20 0.39
ALDH1A1 P00352 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30905353 0.87 LMNA (0.42) CXCR2TDP1L3MBTL1PTGS1ALDH1A1
SCHEMBL1820336 0.85 PTGS1 (0.53) KMT2ACXCR2PTGS1PTGS2MEN1
SCHEMBL28094253 0.82 TDP1 (0.56) KMT2ATDP1L3MBTL1KLK7MTNR1A
SCHEMBL11373799 0.80 PTGS1 (0.60) KMT2ATDP1L3MBTL1PTGS1PTGS2
Hydrogen Peroxide SCHEMBL11143418 0.79 CXCR2 (0.46) KMT2ACXCR2TDP1PTGS1MEN1
SCHEMBL1821733 0.78 PTGS1 (0.61) KMT2ACXCR2PTGS1PTGS2MEN1
SCHEMBL8007159 0.77 CXCR2 (0.43) CXCR2TDP1PTGS1CXCR1ALDH1A1
SCHEMBL1578804 0.76 KMT2A (0.69) KMT2ATDP1L3MBTL1PTGS1PTGS2
SCHEMBL2494755 0.75 FFAR1 (0.40) CXCR2L3MBTL1MTNR1AMTNR1BALDH1A1
SCHEMBL2501280 0.75 FFAR1 (0.40) CXCR2L3MBTL1MTNR1AMTNR1BALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3484879-B1 HYDROXYQUINOLINONE COMPOUNDS HAVING MUSCARINIC RECEPTOR ANTAGONIST AND BETA2 ADRENERGIC RECEPTOR AGONIST ACTIVITY CHIESI FARM SPA (IT) 2020-12-30 EP disclosed
WO-2018011090-A1 HYDROXYQUINOLINONE COMPOUNDS HAVING MUSCARINIC RECEPTOR ANTAGONIST AND BETA2 ADRENERGIC RECEPTOR AGONIST ACTIVITY CHIESI FARMACEUTICI S.P.A. (IT) 2018-01-18 WO disclosed